Core Laboratories NV (CLB) Shares Up 2.8%
Core Laboratories NV (NYSE:CLB) shares shot up 2.8% during mid-day trading on Thursday . The stock traded as high as $125.43 and last traded at $125.04, with a volume of 220,919 shares. The stock had previously closed at $121.64.
Several research firms have recently issued reports on CLB. Citigroup Inc. restated a “hold” rating on shares of Core Laboratories NV in a research report on Saturday, March 19th. Cowen and Company reaffirmed a “hold” rating on shares of Core Laboratories NV in a research note on Saturday, April 23rd. Simmons reaffirmed a “hold” rating and set a $115.00 price objective (up previously from $105.00) on shares of Core Laboratories NV in a research note on Saturday, April 23rd. Royal Bank Of Canada reaffirmed a “buy” rating on shares of Core Laboratories NV in a research note on Saturday, April 23rd. Finally, KLR Group reaffirmed a “buy” rating and set a $180.00 price objective (up previously from $166.00) on shares of Core Laboratories NV in a research note on Monday, June 13th. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and seven have issued a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $119.94.
The company has a 50-day moving average price of $123.18 and a 200-day moving average price of $113.11. The firm has a market capitalization of $5.25 billion and a price-to-earnings ratio of 53.59.
Core Laboratories NV (NYSE:CLB) last released its quarterly earnings data on Wednesday, April 20th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.37. The company had revenue of $153.65 million for the quarter, compared to the consensus estimate of $161.24 million. Core Laboratories NV’s revenue for the quarter was down 28.1% compared to the same quarter last year. During the same period last year, the company earned $0.86 EPS. On average, equities analysts forecast that Core Laboratories NV will post $1.62 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 15th. Stockholders of record on Monday, July 18th will be given a dividend of $0.55 per share. The ex-dividend date of this dividend is Thursday, July 14th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 1.78%.
Other institutional investors recently added to or reduced their stakes in the company. Comerica Bank boosted its position in Core Laboratories NV by 1.0% in the fourth quarter. Comerica Bank now owns 23,101 shares of the company’s stock worth $2,246,000 after buying an additional 239 shares during the period. Swiss National Bank boosted its position in Core Laboratories NV by 1.2% in the fourth quarter. Swiss National Bank now owns 77,200 shares of the company’s stock worth $8,395,000 after buying an additional 900 shares during the period. Howland Capital Management LLC boosted its position in Core Laboratories NV by 4.7% in the fourth quarter. Howland Capital Management LLC now owns 102,070 shares of the company’s stock worth $11,099,000 after buying an additional 4,562 shares during the period. Ameritas Investment Partners Inc. bought a new position in Core Laboratories NV during the fourth quarter worth about $1,043,000. Finally, Sawtooth Asset Management Inc. boosted its position in Core Laboratories NV by 992.9% in the fourth quarter. Sawtooth Asset Management Inc. now owns 17,923 shares of the company’s stock worth $1,949,000 after buying an additional 16,283 shares during the period.
Core Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company’s services and products are directed toward enabling the Company’s clients to improve reservoir performance and increase oil and gas recovery from their producing fields.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.